(Q46010463)

18 December 2017

title

Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment. (English)

1 reference

18 December 2017

1 reference

2

1 reference

18 December 2017

author name string

Jin Y

series ordinal

1

1 reference

18 December 2017

Sandman CA

series ordinal

3

1 reference

18 December 2017

Bunney WE Jr

series ordinal

4

1 reference

18 December 2017

publication date

1 April 1998

1 reference

18 December 2017

Clinical EEG (electroencephalography)

published in

1 reference

18 December 2017

volume

29

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

73-78

1 reference

18 December 2017

EEG and human psychopharmacology

cites work

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

EEG-brain mapping. A method to optimize therapy in schizophrenics using absolute power and center frequency values

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Paroxysmal EEG Activity and Psychopathology During the Treatment with Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Tolerability of long term clozapine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

EEG alterations and seizures during treatment with clozapine. A retrospective study of 283 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

EEG Profile Studies of Clozapine in Volunteers and Psychiatric Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Abnormal EEG responses to photic stimulation in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

EEG alpha photic driving abnormalities in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Neural mechanisms underlying brain waves: from neural membranes to networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Topographic analysis of EEG photic driving in normal and schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Electroencephalographic photic driving in patients with schizophrenia and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Clozapine increases EEG photic driving in clinical responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Brain electrical activity mapping (BEAM): A method for extending the clinical utility of EEG and evoked potential data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Dyslexia: automated diagnosis by computerized classification of brain electrical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Significance probability mapping: An aid in the topographic analysis of brain electrical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

The effects of a 5-HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Effects of sertindole on sleep-wake states, electroencephalogram, behavioral patterns, and epileptic activity of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F155005949802900205

10.1177/155005949802900205

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017